Dietary Supplementation and Hydration

November 2, 2026 updated by: Tom Clifford, Loughborough University

This study will examine the effects of protein drinks on markers of hydration in healthy young males and females.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Leicestershire
      • Loughborough, Leicestershire, United Kingdom
        • Loughborough University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy, physically active

Exclusion Criteria:

Are not between the ages of 18-40. If you are not considered at least recreationally physically active (at least meeting the WHO criteria) - Tier 1 or Tier 2 on the Participant Classification Framework (https://pubmed.ncbi.nlm.nih.gov/34965513/).

Have metabolic, inflammatory, vascular, renal disease or any other complication that would contradict the study procedures or risk your health.

Currently taking medication or supplements that may interfere with the study outcomes.

  • Do not satisfactorily complete the health history survey
  • You have any allergies to the ingredients in the supplements

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Protein

Protein (10 g of protein powder and 500 ml of water)

10 g of protein powder in 500 ml water

10 g of protein powder, plus sodium chloride (20 mmol/L) in 500 ml of water

Experimental: Protein+

Protein (10 g of protein powder, 500 ml of water, sodium chloride, 20 mmol/L)

10 g of protein powder in 500 ml water

10 g of protein powder, plus sodium chloride (20 mmol/L) in 500 ml of water

Placebo Comparator: Placebo control

Water (500 ml)

Water (500 ml)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Urine output (mass in grams over 180 min collection period)
Time Frame: 180 minutes
180 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective measures of thirst (Likert scale, 0-10; 0 = low, 10 = high)
Time Frame: Pre - then 30, 60, 120, 180 mins post
Pre - then 30, 60, 120, 180 mins post
Urine specific gravity (AU)
Time Frame: Pre - then 60, 120, 180 mins post
Pre - then 60, 120, 180 mins post
Blood sodium concentrations (mmol)
Time Frame: Pre - then 30, 60, 120, 180 mins post
Pre - then 30, 60, 120, 180 mins post
Blood chloride concentrations (mmol)
Time Frame: Pre - then 30, 60, 120, 180 mins post
Pre - then 30, 60, 120, 180 mins post
Blood potassium (mmol)
Time Frame: Pre - then 30, 60, 120, 180 mins post
Pre - then 30, 60, 120, 180 mins post
Urine sodium (mmol)
Time Frame: Pre - then 30, 60, 120, 180 mins post
Pre - then 30, 60, 120, 180 mins post
Urine chloride (mmol)
Time Frame: Pre - then 30, 60, 120, 180 mins post
Pre - then 30, 60, 120, 180 mins post
Urine potassium (mmol)
Time Frame: Pre - then 30, 60, 120, 180 mins post
Pre - then 30, 60, 120, 180 mins post
Plasma volume change (% change)
Time Frame: Pre - then 60, 180 minutes
Pre - then 60, 180 minutes
Plasma albumin concentrations
Time Frame: Pre - then 60, 180 minutes

ELISA measurement

Pre - then 60, 180 minutes
Plasma aldosterone concentrations
Time Frame: Pre - then 60, 180 minutes

ELISA measurement

Pre - then 60, 180 minutes
Subjective measure of hunger (Likert scale, 0-10; 0 = low, 10 = high)
Time Frame: Pre - then 30, 60, 120, 180 mins post
Pre - then 30, 60, 120, 180 mins post
Subjective measure of gastrointestinal stress (Likert scale, 0-10; 0 = low, 10 = high)
Time Frame: Pre - then 30, 60, 120, 180 mins post
Pre - then 30, 60, 120, 180 mins post
Plasma insulin concentrations
Time Frame: Pre - then 60, 180 minutes

ELISA measurement

Pre - then 60, 180 minutes
Subjective measures of hunger (Likert scale, 0-10; 0 = low, 10 = high)
Time Frame: Pre - then 30, 60, 120, 180 mins post
Pre - then 30, 60, 120, 180 mins post
Subjective measures of stomach fullness (Likert scale, 0-10; 0 = low, 10 = high)
Time Frame: Pre - then 30, 60, 120, 180 mins post
Pre - then 30, 60, 120, 180 mins post
Subjective measures of nausea (Likert scale, 0-10; 0 = low, 10 = high)
Time Frame: Pre - then 30, 60, 120, 180 mins post
Pre - then 30, 60, 120, 180 mins post
Beverage hydration index (AU)
Time Frame: Pre - then 30, 60, 120, 180 mins post

Calculated as the ratio of cumulative urine mass for water/cumulative urine mass of the test beverages

Pre - then 30, 60, 120, 180 mins post
Plasma osmolality (mOsm/L)
Time Frame: Pre - 60, 180 mins post
Pre - 60, 180 mins post
Blood glucose (mmol/L)
Time Frame: Pre - then 30, 60, 120, 180 mins post
Pre - then 30, 60, 120, 180 mins post

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 30, 2026

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

October 1, 2027

Study Registration Dates

First Submitted

November 2, 2026

First Submitted That Met QC Criteria

November 2, 2026

First Posted (Actual)

November 6, 2026

Study Record Updates

Last Update Posted (Actual)

November 6, 2026

Last Update Submitted That Met QC Criteria

November 2, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 24748

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe